ESC 365 - Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

ESC Premium Access

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes

Topic: Biomarkers

Speaker: Associate Professor B. Rocca (Rome, IT)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Associate Professor Bianca Rocca

Catholic University School of Medicine, Rome (Italy)

11 presentations

0 follower

6 more presentations in this session

Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)

Speaker: Professor G. Boriani (Modena, IT)

Atrial fibrillation risk factor burden and disease onset across age decades.

Speaker: Associate Professor B. Morseth (Tromso, NO)

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis.

Speaker: Assistant Professor D. Pastori (Rome, IT)

Long term antithrombotic treatment in atrial fibrillation patients undergoing coronary surgery.

Speaker: Doctor M. Skibniewski (Linkoping, SE)

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Speaker: Doctor J. Sen (Melbourne, AU)

Access the full session

Atrial Fibrillation, Platelet Aggregation and Outcomes

Speakers: Associate Professor B. Rocca, Professor G. Boriani, Associate Professor B. Morseth, Assistant Professor D. Pastori, Doctor M. Skibniewski...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by